PM14

DRUG4 trials

Sponsors

Pharma Mar S.A., Asoc Grupo Espanol De Investigacion En Sarcomas, PharmaMar, Grupo Espanol de Investigacion en Sarcomas

Conditions

Advanced L-sarcomasAdvanced Soft-tissue SarcomaAdvanced Solid TumorLocalized Soft-tissue SarcomaOther Advanced SarcomasPatients with Selected Advanced Solid TumorsSoft tissue sarcomas and other solid tumors

Phase 1

PM14 Administered Intravenously to Patients With Advanced Solid Tumors

CompletedNCT05076396

PharmaMarAdvanced Solid Tumor

Start: 2017-09-06End: 2025-08-21Updated: 2026-05-11

Multicohort Trial of Different Schemes of PM14 in Monotherapy and in Combination with Radiotherapy in Soft Tissue Sarcomas and Other Solid Tumor

RecruitingNCT05146440

Grupo Espanol de Investigacion en SarcomasAdvanced L-sarcomas, Advanced Soft-tissue Sarcoma, Advanced Solid Tumor +2

Start: 2021-11-23End: 2026-05-31Target: 195Updated: 2025-03-21

Phase Ib/II multicohort trial of different schemes of PM14 in monotherapy and in combination with radiotherapy in soft tissue sarcomas and other solid tumors

RecruitingCTIS2024-519893-38-00

Asoc Grupo Espanol De Investigacion En SarcomasSoft tissue sarcomas and other solid tumors

Start: 2021-11-23Target: 195Updated: 2024-12-19

Phase 2

Phase I/II, Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM14 in Combination with Irinotecan in Pretreated Patients with Selected Advanced Solid Tumors

CompletedCTIS2024-514890-24-00

Pharma Mar S.A.Patients with Selected Advanced Solid Tumors

Start: 2021-07-23End: 2025-07-16Target: 45Updated: 2025-02-03